{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:36Z","timestamp":1791262596171,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    This study aimed to investigate the influence of baseline blood lipid profiles on therapeutic efficacy and adverse events (AEs) among cancer patients treated with immune checkpoint inhibitors (ICIs). We retrospectively analyzed patients with solid tumors who received ICIs, with a focus on their blood lipid profiles at baseline. Associations between dyslipidemia and clinical outcomes following ICI therapy were assessed using both univariate and multivariable analyses. A total of 99 eligible patients were included: 52 with renal cell carcinoma, 23 with urothelial carcinoma, and 24 with esophageal carcinoma. Among patients with renal cell carcinoma, low\u2010density lipoprotein (LDL) cholesterol \u2265\u2009140\u2009mg\/dL (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.013) and high\u2010density lipoprotein (HDL) cholesterol \u2264\u200940\u2009mg\/dL (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.040) were significantly associated with shorter overall survival. Conversely, among patients with esophageal carcinoma, LDL cholesterol \u2265\u2009120\u2009mg\/dL was associated with longer progression\u2010free survival (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.035). Among all patients, HDL cholesterol &lt;\u200940\u2009mg\/dL was identified as a risk factor for Grade 3 or higher AEs (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.018), especially liver injury (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.033). Prior statin use was associated with a trend toward an improved response to ICIs among patients with renal cell carcinoma (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.057). Baseline blood lipid profiles\u2014particularly LDL and HDL cholesterol levels\u2014may influence clinical outcomes among cancer patients receiving ICI therapy. These findings suggest that lipid profiles might serve as predictive biomarkers for the efficacy and safety of ICIs.\n                  <\/jats:p>","DOI":"10.1002\/cam4.72286","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:15:53Z","timestamp":1789100153000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Dyslipidemia on Clinical Outcomes Among Cancer Patients Treated With Immune Checkpoint Inhibitors"],"prefix":"10.1002","volume":"15","author":[{"given":"Yao","family":"Liang","sequence":"first","affiliation":[{"name":"Division of Clinical Oncology and Chemotherapy, Department of Integrated Medicine Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4700-6541","authenticated-orcid":false,"given":"Osamu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology and Chemotherapy Nagoya University Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-4781","authenticated-orcid":false,"given":"Shohei","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8455-7364","authenticated-orcid":false,"given":"Kenji","family":"Zennami","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-1260","authenticated-orcid":false,"given":"Tomokazu","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-5771","authenticated-orcid":false,"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5665-528X","authenticated-orcid":false,"given":"Tomoyasu","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-9637","authenticated-orcid":false,"given":"Kazushi","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Surgery Nagoya University Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7982-1079","authenticated-orcid":false,"given":"Dai","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Surgery Nagoya University Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0367-8557","authenticated-orcid":false,"given":"Kazuki","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Kyoto University School of Public Health  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-2489","authenticated-orcid":false,"given":"Basile","family":"Chr\u00e9tien","sequence":"additional","affiliation":[{"name":"Department of International Medical Education Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuro","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Surgery Nagoya University Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-7506","authenticated-orcid":false,"given":"Shusuke","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Department of Urology Nagoya University Graduate School of Medicine  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-2297","authenticated-orcid":false,"given":"Yuichi","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Clinical Oncology and Chemotherapy, Department of Integrated Medicine Nagoya University Graduate School of Medicine  Nagoya Japan"},{"name":"Department of Clinical Oncology and Chemotherapy Nagoya University Hospital  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.10.001"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad184"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad273"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.10.031"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1448966"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02979-4"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.GL2022"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008146"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.468967"},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/CBM-150544","article-title":"High BMI and Low HDL\u2010C Predict the Chemotherapy\u2010Related Hepatic Dysfunction in Chinese Advanced NSCLC Patients","volume":"16","author":"Lv Y.","year":"2016","journal-title":"Cancer Biomarkers: Section A of Disease Markers"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1205"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30229"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.028"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102513"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15651"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109687"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01200-4"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161940"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(99)00045-5"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf039"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2020.100020"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.72286","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cam4.72286","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.72286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:48:31Z","timestamp":1791262111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.72286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/cam4.72286"],"URL":"https:\/\/doi.org\/10.1002\/cam4.72286","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"value":"2045-7634","type":"print"},{"value":"2045-7634","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e72286"}}